Pith. sign in

BARTSmiles: Generative Masked Language Models for Molecular Representations

1 Pith paper cite this work. Polarity classification is still indexing.

1 Pith paper citing it
abstract

We discover a robust self-supervised strategy tailored towards molecular representations for generative masked language models through a series of tailored, in-depth ablations. Using this pre-training strategy, we train BARTSmiles, a BART-like model with an order of magnitude more compute than previous self-supervised molecular representations. In-depth evaluations show that BARTSmiles consistently outperforms other self-supervised representations across classification, regression, and generation tasks setting a new state-of-the-art on 11 tasks. We then quantitatively show that when applied to the molecular domain, the BART objective learns representations that implicitly encode our downstream tasks of interest. For example, by selecting seven neurons from a frozen BARTSmiles, we can obtain a model having performance within two percentage points of the full fine-tuned model on task Clintox. Lastly, we show that standard attribution interpretability methods, when applied to BARTSmiles, highlight certain substructures that chemists use to explain specific properties of molecules. The code and the pretrained model are publicly available.

fields

cs.LG 1

years

2025 1

verdicts

CONDITIONAL 1

representative citing papers

NovoMolGen: Rethinking Molecular Language Model Pretraining

cs.LG · 2025-08-19 · conditional · novelty 6.0

A 1.5-billion-molecule pretrained transformer family, NovoMolGen, sets new state-of-the-art results in de novo and goal-directed molecule generation, and shows pretraining loss correlates only weakly with downstream generation quality.

citing papers explorer

Showing 1 of 1 citing paper.

  • NovoMolGen: Rethinking Molecular Language Model Pretraining cs.LG · 2025-08-19 · conditional · none · ref 8 · internal anchor

    A 1.5-billion-molecule pretrained transformer family, NovoMolGen, sets new state-of-the-art results in de novo and goal-directed molecule generation, and shows pretraining loss correlates only weakly with downstream generation quality.